Endologix, Inc. to Present at the J.P. Morgan Healthcare Conference
December 19 2017 - 4:01PM
Business Wire
Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of
innovative treatments for aortic disorders, today announced that
John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief
Financial Officer, will present at the 36th Annual J.P. Morgan
Healthcare Conference at 1:30 p.m. PT on Monday, January 8, 2018 in
San Francisco, CA.
A live webcast of the presentation and Q&A breakout session
will be accessible through the “Investors” section of the Company’s
website at www.endologix.com and will be available for replay
following the event.
About Endologix, Inc.Endologix, Inc. develops and
manufactures minimally invasive treatments for aortic disorders.
The Company's focus is endovascular stent grafts for the treatment
of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall
of the aorta, the largest artery in the body, resulting in a
balloon-like enlargement. Once AAA develops, it continues to
enlarge and, if left untreated, becomes increasingly susceptible to
rupture. The overall patient mortality rate for ruptured AAA is
approximately 80%, making it a leading cause of death in the United
States. For more information, visit www.endologix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171219005934/en/
INVESTORS:Endologix, Inc.Vaseem Mahboob,
949-595-7200CFO
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Apr 2023 to Apr 2024